Pathological Conditions, Signs and Symptoms

144 trials 75 recruiting

Filter these 144 trials by phase, country and sponsor.

Open in Search →

TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Not authorised

2024-511807-41-00 Hemophagocytic lymphohistiocytosis (HLH) 5
Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-00 Medical expulsive therapy using diuretics and alpha-blo 5
Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-01 Medical expulsive therapy using diuretics and alpha-blo 5
A Clinical Trial of OM336 to Help Immunized Patients Become Eligible for Kidney Transplantation Not authorised

2025-523222-40-00 End stage renal failure 4
MOOD - MethOxyflurane analgesia in vasoOcclusive crises of sickle cell Disease Not authorised

2024-518043-38-00 Sickle cell disease 5
Vi-Siblin for LARS: A randomized, controlled trial. Pending

2024-514541-11-00 Low anterior resection syndrome after low anterior rese 4
TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Pending

2024-511807-41-01 Hemophagocytic lymphohistiocytosis (HLH) 5
MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Pending

2025-522710-22-00 Cancer, bone metastasis, pain 6
Iron Infusion in Elderly Patients undergoing Transcatheter Aortic Valve Implantation (IRON TAVI) Trial Pending

2023-505095-29-03 Patients with Aortic stenosis and Iron deficiency 6
Which is the best treatment to relieve severe acute pain in the prehospital phase : Morphine or alfentanil ? Pending

2025-522817-50-00 Severe pain 6
Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants Pending

2025-522935-32-00 interstitial cystitis/bladder pain syndrome 3
Anticoagulant medicines for Balloon Pulmonary Angioplasty Pending

2024-518803-23-00 Chronic Thromboembolic Pulmonary Hypertension (CTEPH) 6
Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with … Pending

2025-523806-34-00 relapsed/refractory Large B-Cell Lymphoma 4
NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase… Pending

2023-508977-10-00 Liver Transplant 9
THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: TH… Pending

2025-525006-37-00 Infection and sepsis 5
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl Pending

2024-517506-29-00 Bioequivalence trial in healthy volunteers 2
Assessment of the impairment of the serotoninergic system during the prodromal phase of Parkinson’s disease in SNCA mutation carriers by PET… Pending

2024-516610-38-00 Parkinson's disease 10
CIRAANO: Multimodal exploration of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strat… Pending

2025-523264-21-00 Semantic Variant Primary Progressive Aphasia 10
Pharmacokinetic study of the use of Nefopam 30 mg tablet in patients suffering from acute pain in rheumatology - NEFOPAIN kinetics Pending

2025-521926-13-00 Hospitalized patient with acute rheumatological pain, r 6
A randomized phase III trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III … Pending

2024-519031-42-00 pancreatic ductal adenocarcinoma 5
Multicentric study evaluating the usefulness of early PSMA PET scan in metastatic renal cancer requiring standard immunotherapy treatment. Pending

2024-517098-26-00 metastatic clear cell Renal Carcinoma Cell 4
Evaluation of the Pharmacokinetics of Subcutaneous Administration of Piperacillin/Tazobactam: An Open-Label, Multicentric, Non-Inferiority R… Pending

2024-519663-17-01 Infectious disease 4
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
A Phase 2, Multi-center, Randomized, Dose-Ranging, Placebo-Controlled, Double-blind Study of the Relaxin Agonist R2R01 in Patients at High R… Recruiting

2025-523037-25-00 Patients at high risk for Cardiac Surgery Associated – 4 2026-03-10